ABSTRACT
BACKGROUND AND PURPOSE: Pharmacological validation of novel functions for the alpha2A-, alpha2B-, and alpha2C-adrenoceptor (AR) subtypes has been hampered by the limited specificity and subtype-selectivity of available ligands. The current study describes a novel highly selective alpha2C-adrenoceptor antagonist, JP-1302 (acridin-9-yl-[4-(4-methylpiperazin-1-yl)-phenyl]amine). EXPERIMENTAL APPROACH: Standard in vitro binding and antagonism assays were employed to demonstrate the alpha2C-AR specificity of JP-1302. In addition, JP-1302 was tested in the forced swimming test (FST) and the prepulse-inhibition of startle reflex (PPI) model because mice with genetically altered alpha2C-adrenoceptors have previously been shown to exhibit different reactivity in these tests when compared to wild-type controls. KEY RESULTS: JP-1302 displayed antagonism potencies (KB values) of 1,500, 2,200 and 16 nM at the human alpha2A-, alpha2B-, and alpha2C-adrenoceptor subtypes, respectively. JP-1302 produced antidepressant and antipsychotic-like effects, i.e. it effectively reduced immobility in the FST and reversed the phencyclidine-induced PPI deficit. Unlike the alpha2-subtype non-selective antagonist atipamezole, JP-1302 was not able to antagonize alpha2-agonist-induced sedation (measured as inhibition of spontaneous locomotor activity), hypothermia, alpha2-agonist-induced mydriasis or inhibition of vas deferens contractions, effects that have been generally attributed to the alpha2A-adrenoceptor subtype. In contrast to JP-1302, atipamezole did not antagonize the PCP-induced prepulse-inhibition deficit. CONCLUSIONS AND IMPLICATIONS: The results provide further support for the hypothesis that specific antagonism of the alpha2C-adrenoceptor may have therapeutic potential as a novel mechanism for the treatment of neuropsychiatric disorders.
Subject(s)
Acridines/pharmacology , Adrenergic alpha-Antagonists/pharmacology , Central Nervous System/drug effects , Piperazines/pharmacology , Receptors, Adrenergic, alpha-2/drug effects , Adrenergic alpha-Agonists/pharmacology , Animals , Antidepressive Agents/pharmacology , Binding, Competitive/drug effects , Cell Membrane/drug effects , Dexmedetomidine/antagonists & inhibitors , Dexmedetomidine/pharmacology , Dose-Response Relationship, Drug , Electric Stimulation , Humans , Hypothermia/chemically induced , In Vitro Techniques , Male , Mice , Motor Activity/drug effects , Muscle Contraction/drug effects , Muscle, Smooth/drug effects , Radioligand Assay , Rats , Rats, Sprague-Dawley , Reflex, Startle/drug effects , Swimming/psychology , Vas Deferens/drug effectsABSTRACT
This study examined the effects of monoamine oxidase (MAO) inhibitors on N-methyl-D-aspartic acid (NMDA)-induced perturbation of neurotransmission and normal NMDA-receptor dependent function (long-term potentiation, LTP) in the CA1 field of hippocampus. During baseline recording, neurotransmission was unaffected by long-term bath perfusion with MAO inhibitors (selegiline, pargyline). After NMDA (100 microM) infusion, the presence of selegiline (1 microM) promoted the recovery rate and increased the size of recovered extracellular field excitatory postsynaptic potentials (fEPSPs). Selegiline (1 microM) also prevented the NMDA-induced increase in paired pulse facilitation (PPF). The induction and maintenance of LTP were normal with this same concentration of selegiline. The presence of lower concentration (10 nM) of selegiline or pargyline (1 microM) did not improve the recovery process. These results suggest that selegiline partially protects the function of CA3-CA1 hippocampal connections against overactivation of NMDA receptors. Further, the same concentration of selegiline does not interfere with the physiological function of NMDA receptors in the CA1 field of the hippocampus. The exact mechanism of action remains to be determined, but it is apparently downstream to the overactivation of NMDA receptors.
Subject(s)
Hippocampus/drug effects , Long-Term Potentiation/drug effects , N-Methylaspartate/pharmacology , Receptors, N-Methyl-D-Aspartate/drug effects , Selegiline/pharmacology , Synaptic Transmission/drug effects , Animals , Dose-Response Relationship, Drug , Drug Interactions/physiology , Excitatory Postsynaptic Potentials/drug effects , Excitatory Postsynaptic Potentials/physiology , Glutamic Acid/metabolism , Hippocampus/metabolism , In Vitro Techniques , Long-Term Potentiation/physiology , Male , Monoamine Oxidase Inhibitors/pharmacology , N-Methylaspartate/antagonists & inhibitors , Neurons/drug effects , Neurons/metabolism , Pargyline/pharmacology , Rats , Rats, Wistar , Receptors, N-Methyl-D-Aspartate/metabolism , Synaptic Transmission/physiologyABSTRACT
Rats with a deficit in selective attention accompanied by impulsivity can be identified using a five-choice serial reaction time task (5-CSRT) and have been proposed to represent a rodent model of attention-deficit hyperactivity disorder (ADHD). The aim of the present study was to investigate which brain areas are important for visuospatial attention and to test the specific hypothesis that dysfunction of the frontal cortex is related to the behavioral deficits observed in poorly performing rats. Therefore, [(14)C]deoxyglucose (DG) uptake, an index of brain metabolic activity, was measured during the performance of a 5-CSRT task in two populations of rats (poorly and well-performing rats) to study the relationships between the regional brain activity and behavioral output. While performing a 5-CSRT task, poorly performing rats exhibited lower DG uptake in the cingulate and ventrolateral orbital cortices than did well-performing rats,. Moreover, there was a positive correlation between choice accuracy and DG uptake in several areas, especially in the frontal and parietal regions, whereas there was an inverse correlation between the percentage of premature responses and DG uptake in the ventrolateral orbital and cingulate cortices. These results, which demonstrated that the poorly performing rats exhibited metabolic dysfunction in the cingulate and prefrontal cortices, provide a basis for the face validity of the rodent model of ADHD. Moreover, they suggest that the neural network of attention in rats is remarkably analogous to that described in primates.
Subject(s)
Attention Deficit Disorder with Hyperactivity/metabolism , Behavior, Animal/physiology , Gyrus Cinguli/metabolism , Prefrontal Cortex/metabolism , Reaction Time/physiology , Animals , Attention Deficit Disorder with Hyperactivity/physiopathology , Brain Mapping/methods , Deoxyglucose/metabolism , Disease Models, Animal , Gyrus Cinguli/physiology , Male , Neurons/physiology , Prefrontal Cortex/physiology , Rats , Rats, Wistar , Spatial Behavior/physiology , Visual Cortex/physiopathologyABSTRACT
To determine if the inhibition of MAO-A and/or MAO-B activities can influence cognitive processes in adult rats, we analysed whether chronic treatment with clorgyline, 1-deprenyl and pargyline could modify the performance of adult rats in a modified version of the water maze task. The effects of these treatments on locomotor activity and enzyme activities were also assessed. Rats were treated for 24 days with clorgyline (0.2 mg/kg), 1-deprenyl (0.25 mg/kg) and pargyline (I or 10 mg/kg). The treatments were started two weeks before the water maze experiment and continued until the end of testing. The rats were trained to find a submerged platform (6 days: I trial/day; 7 th day: probe trial). Over the next three days, locomotor activity was assessed in an open arena. Treatments with clorgyline (MAO-A inhibitor), 1-deprenyl (MAO-B inhibitor) and pargyline (non-selective MAO inhibitor) did not improve the finding of the hidden platform, when compared to treatment with saline, but significantly increased the swimming speed of the rats. The different treatments, when compared to saline, failed to modify the distance covered and the number of groomings performed in the open arena. However, clorgyline and pargyline, 10 mg/kg, increased the number of faecal boli and clorgyline enhanced the number of rearings made when compared to saline, 1-deprenyl and pargyline, 10 mg/kg. These results indicate that near total inhibition of MAO-A by clorgyline and pargyline as assessed by MAO activity measurement induces an increase in locomotor activity but that inhibition of MAO-A or MAO-B, either alone or combined, does not facilitate spatial learning in adult rats.
Subject(s)
Clorgyline/pharmacology , Maze Learning/drug effects , Memory/drug effects , Monoamine Oxidase Inhibitors/pharmacology , Pargyline/pharmacology , Selegiline/pharmacology , Animals , Behavior, Animal/drug effects , Clorgyline/therapeutic use , Male , Monoamine Oxidase Inhibitors/therapeutic use , Motor Activity/drug effects , Pargyline/therapeutic use , Rats , Rats, Wistar , Selegiline/therapeutic use , Swimming , Weight Gain/drug effectsABSTRACT
Previous studies suggest that enhanced noradrenergic neurotransmission promotes functional recovery following cerebral lesions. The present study investigated whether systemic administration of an alpha(2)-adrenergic antagonist, atipamezole, facilitates recovery following transient focal cerebral ischemia in rats. The effect of atipamezole therapy on recovery from ischemia was compared with the effect of enriched-environment housing in rats. Ischemia was induced by occlusion of the right middle cerebral artery (MCA) for 120 min using the intraluminal filament model. Daily atipamezole treatment (1 mg/kg, subcutaneously) was started on day 2 after ischemia induction and drug administration stopped after 10 days. Another group of rats was housed in an enriched environment from day 2 following ischemia induction until the end of the experiment. Several different behavioral tests were used to measure functional recovery during the 26 days following the induction of focal cerebral ischemia. There was improved performance in the limb-placing test from the beginning of atipamezole treatment to day 8, and in wheel-running in the foot-slip test on days 2 and 4. Enriched-environment housing facilitated recovery in the foot-slip test in a later phase of the test period (days 8 to 10). Discovery of a hidden platform in a water-maze task was also facilitated in rats housed in the enriched environment, but this was probably due to the increased swimming speed of these rats. The present data suggest that the alpha(2)-adrenergic antagonist, atipamezole, facilitates sensorimotor recovery after focal ischemia, but has no effect on subsequent water-maze tests assessing spatial learning and memory, when assessed 11 days after the cessation of drug administration.
Subject(s)
Adrenergic alpha-2 Receptor Antagonists , Adrenergic alpha-Antagonists/pharmacology , Behavior, Animal/drug effects , Imidazoles/pharmacology , Ischemic Attack, Transient/physiopathology , Analysis of Variance , Animals , Ischemic Attack, Transient/pathology , Male , Maze Learning/drug effects , Neuropsychological Tests , Psychomotor Performance/drug effects , Rats , Rats, Wistar , Receptors, Adrenergic, alpha-2/physiologyABSTRACT
The present study examined whether housing in an enriched environment affects hippocampal function in responding to the challenge of a spatial water maze task in naive rats and following transient global ischemia. The enriched-environment housing was used for 11 days and was instituted the day after the induction of 20-min ischemia. Thereafter, the rats were tested in the water maze. The function of hippocampal neurons was assessed by Fos-immunostaining in ischemic and sham-operated rats 3 h after water maze testing. Rats housed in an enriched environment had an increased number of Fos-positive neurons per section in the granule cell layer of the dentate gyrus compared to rats housed individually in standard cages. This increase was observed in both ischemic and sham-operated rats. The experimental groups showed no differences in the number of Fos-positive cells in different hippocampal areas when the rats were placed in the enriched environment for the same period without the learning task. These results suggest that the number of neurons responding with altered gene expression in the dentate gyrus is increased in rats housed in an enriched environment following training in a water maze task. The altered gene expression is also preserved in ischemic rats.
Subject(s)
Dentate Gyrus/metabolism , Environment , Ischemic Attack, Transient/metabolism , Maze Learning , Proto-Oncogene Proteins c-fos/metabolism , Animals , Behavior, Animal , Cell Count , Dentate Gyrus/blood supply , Dentate Gyrus/pathology , Disease Models, Animal , Housing, Animal , Immunohistochemistry , Ischemic Attack, Transient/physiopathology , Male , Neurons/metabolism , Neurons/pathology , Rats , Rats, WistarABSTRACT
The present experiments investigated whether the enhanced premature (impulsive) responding induced by DOI, [(+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane hydrochloride], a 5-HT2A/2C receptor agonist, is mediated by activation of the dopaminergic system and if this effect of DOI occurs in the nucleus accumbens. Therefore, the effects of a dopamine (D1/2) receptor antagonist given alone or combined with DOI were examined on the performance of rats in a five-choice serial reaction time (5-CSRT) task. Secondly, the effects of DOI in nucleus accumbens core and shell were studied, in order to find the target brain area for DOI-induced premature responding. The results indicate that DOI (0.1 mg/kg, subcutaneously) increases the number of premature responses, as found previously. alpha-Flupenthixol (0.03 mg/kg), a D1/2 dopamine receptor antagonist, and raclopride (0.015 mg/kg), a D2 receptor antagonist, attenuated the DOI-induced enhancement in premature responding. SCH 23390 (0.005 mg/kg), a selective D1 receptor antagonist with little affinity to 5-HT2 receptors totally blocked the effect of DOI. Those doses of DA antagonists did not significantly decrease premature responding when given alone. On the other hand, higher doses of all of these dopamine antagonists increased the number of omissions and decreased the number of ITI hole responses. In contrast to subcutaneous administration, direct injections of DOI (1, 3, and 10 microg bilaterally) to the nucleus accumbens shell or core had no effect on premature responding. These results suggest that the activation of the dopamine system mediates, at least in part, the effect of a 5-HT2 agonist on premature responding, but the nucleus accumbens is not the primary site for this action.
Subject(s)
Amphetamines/pharmacology , Arousal/drug effects , Attention/drug effects , Dopamine/physiology , Serotonin Receptor Agonists/pharmacology , Animals , Behavior, Animal/drug effects , Benzazepines/pharmacology , Dopamine Antagonists/pharmacology , Flupenthixol/pharmacology , Impulsive Behavior/drug therapy , Impulsive Behavior/physiopathology , Injections, Intraventricular , Male , Nucleus Accumbens/physiology , Raclopride/pharmacology , Rats , Rats, WistarABSTRACT
Selegiline (l-deprenyl) is an irreversible monoamine oxidase B (MAO-B) inhibitor that is suggested to have neuroprotective and neuronal rescuing properties. The present study investigated whether systemic administration of selegiline facilitates behavioral recovery after transient focal cerebral ischemia in rats using a combination of different behavioral tests (limb placing, foot slip, water maze, and Montoya's staircase test) to measure the outcome of recovery. Selegiline (0.5 mg/kg, SC) or 0.9% NaCl was administered once a day, beginning on the second day after induction of ischemia and continuing for 30 days. Selegiline administration combined with enriched-environment housing attenuated ischemia-induced spatial learning deficits in a water-maze task and enhanced performance of both the contralateral affected and ipsilateral nonaffected forelimbs in a staircase test. Selegiline administration alone was not beneficial in any of the tests. Subsequent histologic examination revealed that the infarct volumes were not different between the experimental ischemic groups. Thus, these results suggest that selegiline combined with enriched-environment housing reduces behavioral and cognitive deficits without affecting infarct size.
Subject(s)
Brain Ischemia/drug therapy , Environment , Housing, Animal , Maze Learning/drug effects , Selegiline/administration & dosage , Animals , Behavior, Animal/drug effects , Brain/drug effects , Brain/pathology , Brain Ischemia/pathology , Brain Ischemia/rehabilitation , Disease Models, Animal , Drug Administration Schedule , Forelimb , Male , Motor Activity/drug effects , Rats , Rats, Wistar , Spatial Behavior/drug effectsABSTRACT
The effects of 5-HT(2) receptor ligands on the performance of rats were investigated using a 5-choice serial reaction time (5-CSRT) task. Systemic administration of DOI (0.03 to 0.3 mg/kg subcutaneously [SC]), a 5-HT(2) receptor agonist, did not impair choice accuracy of well-performing rats under either baseline conditions or more demanding conditions of the task, in which the stimulus duration or intensity were reduced or the intertrial interval (ITI) was decreased. DOI (0.1 mg/kg or 0.15 mg/kg) increased premature responding (the probability of intertrial interval hole pokes) in all testing conditions, except under conditions of a short ITI when the rats did not make any hole responses. Ketanserin (0.1 to 0.3 mg/kg SC), a 5-HT(2A) receptor antagonist, had no marked effect on performance. When combined with ketanserin (0.2 mg/kg SC), however, DOI (0.1 mg/kg) did not increase premature responding. The lowest doses of DOI (0.05 and 0.1 mg/kg) that increase premature responding had no effect on open-field performance. Further, the effects of systemically administered DOI were not reproduced by bilateral administration of DOI into the anterior cingulate cortex. These data indicate that excessive activation of 5-HT(2A/2C) receptors interferes with response control rather than visual attention. Furthermore, the DOI-induced enhancement of impulsive responses are not due to locomotor hyperactivity, and the anterior cingulate cortex is not the primary site of action for this enhancement of premature responding.
Subject(s)
Impulsive Behavior/chemically induced , Motor Activity/drug effects , Receptors, Serotonin/drug effects , Serotonin Receptor Agonists/pharmacology , Amphetamines/pharmacology , Animals , Cerebral Cortex/physiology , Impulsive Behavior/psychology , Injections , Injections, Subcutaneous , Ketanserin/pharmacology , Male , Psychomotor Performance/drug effects , Rats , Rats, Wistar , Reaction Time/drug effects , Serotonin Antagonists/pharmacology , Stimulation, ChemicalSubject(s)
Brain-Derived Neurotrophic Factor/metabolism , Gene Expression Regulation/physiology , Hippocampus/physiopathology , Long-Term Potentiation/physiology , Memory Disorders/physiopathology , Receptor, trkB/genetics , Space Perception/physiology , Animals , Hippocampus/pathology , Male , Maze Learning/physiology , Mice , Mice, Transgenic , Receptor, trkB/metabolismABSTRACT
The present experiments investigated the effects of agents acting at serotonin (5-HT)-2 receptors on the performance of rats in a choice serial reaction time (5-CSRT) task in order to examine the role of 5-HT2 receptors in the modulation of attention and response control. The results indicate that DOI, [(+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane hydrochloride; 0.05, 0.1 and 0.2 mg/kg, subcutaneously], a 5-HT(2A/2C) agonist, slightly impaired the choice accuracy of the well performing rats and markedly increased their premature responding. DOI (0.05 and 0.1 mg/kg) had no effect on the latency to collect earned food pellets or to respond correctly, indicating that these lower doses of DOI did not reduce motivation for the food reward in this task. The selective effect of a low dose of DOI (0.1 mg/kg) on premature responding was completely blocked by ketanserin (0.2 mg/kg), a 5-HT2A antagonist, and ritanserin (0.3 mg/kg), a 5-HT(2A/2C) antagonist, but only partially blocked by a high dose of SER082 (1.0 mg/kg), a 5-HT2C antagonist. In contrast to DOI, mCPP, [1-(3-phenyl)piperazine; 0.05 and 0.15 mg/kg], a 5-HT2C agonist, had no effect on choice accuracy or premature responding, but it reduced behavioral activity and/or arousal as indicated by the decreased number of trials completed and increased the probability of omissions. SER082 (1.0 mg/kg) blocked the effects of mCPP on performance. These data suggest that the overactivation of 5-HT2A receptors impairs response control in a 5-CSRT task, whereas the overactivation of 5-HT2C receptors can affect behavioral activity and/or arousal state of the animals for this food rewarded task.
Subject(s)
Amphetamines/pharmacology , Ketanserin/pharmacology , Reaction Time/drug effects , Receptors, Serotonin/drug effects , Serotonin Antagonists/pharmacology , Serotonin Receptor Agonists/pharmacology , Adrenergic alpha-Antagonists/pharmacology , Animals , Male , Piperazines/pharmacology , Rats , Rats, Wistar , Reaction Time/physiology , Receptor, Serotonin, 5-HT2A , Receptor, Serotonin, 5-HT2C , Receptors, Serotonin/physiology , Serial Learning/drug effects , Serial Learning/physiologyABSTRACT
The effects of alpha(2)-adrenoceptor activation on N-methyl-D-aspartic acid (NMDA)-induced perturbation of neurotransmission and normal NMDA-receptor dependent function (long-term potentiation, (LTP)) were investigated in the hippocampal CA1 field in vitro. Bath perfusion of dexmedetomidine hydrochloride (50 nM), which was initiated before NMDA (100 microM) exposure, enhanced the extent of recovery of extracellular field excitatory postsynaptic potentials after NMDA infusion. On the other hand, the induction and early maintenance of LTP was normal in the presence of dexmedetomidine. Thus, dexmedetomidine can diminish acute NMDA-induced perturbation of neurotransmission while the same dose of this drug does not influence the normal activation of NMDA receptors.
Subject(s)
Adrenergic alpha-Agonists/pharmacology , Dexmedetomidine/pharmacology , Excitatory Amino Acid Agonists/pharmacology , Hippocampus/drug effects , N-Methylaspartate/pharmacology , Receptors, N-Methyl-D-Aspartate/agonists , Synaptic Transmission/drug effects , Animals , Excitatory Postsynaptic Potentials , Hippocampus/physiology , In Vitro Techniques , Long-Term Potentiation/physiology , Male , Rats , Rats, Wistar , Receptors, Adrenergic, alpha-2/drug effectsABSTRACT
We investigated the role of overexpression of alpha2C-adrenoceptors in water maze navigation in mice transgenically manipulated to have a threefold overexpression of the alpha2C-adrenoreceptors. Alpha2C-adrenoreceptors overexpressing mice swam more in the peripheral annulus of the pool and did not find the hidden escape platform as well as the wild type control mice. A subtype-nonselective alpha2-adrenoreceptor antagonist, atipamezole (ATI, 1000 microg/kg, s.c.), fully reversed the deficit in platform finding and search strategy in overexpressing mice. Noradrenaline depletion (-95%) induced by N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4) did not impair platform finding of wild type or overexpressing mice. The DSP-4 lesion slightly increased swimming in the peripheral annulus in wild type mice, but not in overexpressing mice. The DSP-4 lesion produced a dissociable effect on the action of atipamezole to improve platform finding and search strategy in overexpressing mice: atipamezole did not alleviate the platform finding deficit in DSP-4 lesioned overexpressing mice, but normalized their abnormal search strategy. These results suggest that the abnormal search pattern and deficit in the accuracy of platform finding are mediated by constitutive activity of overexpressed alpha2C-adrenoreceptors.
Subject(s)
Maze Learning/physiology , Receptors, Adrenergic, alpha-2/genetics , Spatial Behavior/physiology , Adrenergic alpha-Antagonists/pharmacology , Animals , Benzylamines/pharmacology , Exploratory Behavior/drug effects , Exploratory Behavior/physiology , Female , Gene Expression/physiology , Hippocampus/metabolism , Homovanillic Acid/metabolism , Imidazoles/pharmacology , Maze Learning/drug effects , Mice , Mice, Transgenic , Neurotransmitter Uptake Inhibitors/pharmacology , Norepinephrine/metabolism , Retention, Psychology/drug effects , Retention, Psychology/physiology , Spatial Behavior/drug effects , SwimmingABSTRACT
RATIONALE: The cholinergic system is considered to be essential for attention and the degeneration of the cholinergic system in Alzheimer's disease (AD) correlates with the cognitive decline seen in AD patients. The serotonergic system also degenerates in AD, but its role in the modulation of cognitive functions, especially attention, is somewhat unclear. OBJECTIVES: The present study investigated possible differences between cholinergic muscarinic and nicotinic receptor mediated mechanisms, the role of serotonin (5-HT) and the interaction between the cholinergic and serotonergic systems in the modulation of attention and response control. METHODS: The influences of cholinergic receptor blockade and 5-HT lesions on the performance of rats in the five-choice serial reaction time task were assessed. The 5-HT lesions were neurochemically verified. RESULTS: The neurochemical analysis indicated that the levels of 5-HT and 5-hydroxyindoleacetic acid were reduced quite specifically in the hippocampi, parieto-occipital and frontal cortices, and in the striatum of both p-chloroamphetamine (pCA) and 5, 7-dihydroxytryptamine (5,7-DHT) lesioned rats. The behavioural results showed that the pCA lesion caused a transient increase in impulsivity whereas the 5,7-DHT lesion temporarily reduced the motor activity and slightly impaired choice accuracy. Furthermore, the blockade of central muscarinic receptors by scopolamine (0.075 and 0. 150 mg/kg), but not nicotinic receptors by mecamylamine (1.0 or 3.0 mg/kg), impaired the choice accuracy, whereas the blockade of both muscarinic and nicotinic receptors interfered with motor activity, though possibly via peripheral mechanisms. Interestingly, mecamylamine (3.0 mg/kg) reduced impulsivity, whereas scopolamine slightly increased it. Serotonergic lesions did not make the rats more susceptible to the effects of cholinolytics on choice accuracy. CONCLUSIONS: 5-HT system is not essential for the modulation of attention, but it is important in the modulation of response control. Central muscarinic receptors are important in the modulation of attention, whereas central nicotinic receptors may be more essential in response control. The results do not support there being an interaction between the serotonergic and the cholinergic systems in the modulation of attention.
Subject(s)
Attention/drug effects , Muscarinic Antagonists/pharmacology , Nicotinic Antagonists/pharmacology , Receptors, Muscarinic/drug effects , Receptors, Nicotinic/drug effects , 5,7-Dihydroxytryptamine/administration & dosage , Animals , Attention/physiology , Behavior, Animal/drug effects , Brain/drug effects , Brain/metabolism , Cholinergic Antagonists/pharmacology , Cognition/drug effects , Hydroxyindoleacetic Acid/metabolism , Injections, Intraventricular , Male , Nerve Fibers/drug effects , Nerve Fibers/physiology , Neurons/drug effects , Photic Stimulation , Rats , Rats, Wistar , Reaction Time/drug effects , Receptors, Cholinergic/drug effects , Receptors, Cholinergic/metabolism , Receptors, Muscarinic/metabolism , Receptors, Nicotinic/metabolism , Serotonin/metabolism , Serotonin Agents/administration & dosage , Task Performance and Analysis , p-Chloroamphetamine/pharmacologyABSTRACT
The present experiments investigated the effects of a specific and potent alpha(2)-adrenoceptor antagonist, atipamezole, on cognitive performance and neurochemistry in aged rats. Aged control Fisher 344 rats, which had lower activities of choline acetyltransferase in the frontal cortex, were impaired in the acquisition of the linear arm maze task both in terms of repetition errors and their behavioural activity (the speed of arm visits), and they needed longer time to complete this task as compared to adult control rats. Atipamezole treatment (0.3 mg/kg) facilitated the acquisition of this task in the aged rats as they committed fewer errors and completed the task more quickly than saline-treated aged control rats. A separate experiment indicated that atipamezole enhanced the turnover of noradrenaline both in the adult and aged rats, but this effect was more pronounced in the aged rats. Furthermore, atipamezole enhanced significantly the turnover of serotonin and dopamine only in the aged rats when analysed in the whole brain samples. As alpha(2)-adrenoceptor antagonists are known to alleviate akinesia in the experimental models of Parkinson's disease, the present results could be especially relevant for the development of palliative treatment for demented Parkinsonian patients.
Subject(s)
Adrenergic alpha-2 Receptor Antagonists , Adrenergic alpha-Antagonists/pharmacology , Aging/psychology , Biogenic Monoamines/metabolism , Brain/drug effects , Cognition/drug effects , Imidazoles/pharmacology , Aging/metabolism , Animals , Brain/metabolism , Choline O-Acetyltransferase/metabolism , Male , Maze Learning/drug effects , Rats , Rats, Inbred F344ABSTRACT
Oscillations in neuronal networks are assumed to serve various physiological functions, from coordination of motor patterns to perceptual binding of sensory information. Here, we describe an ultra-slow oscillation (0.025 Hz) in the hippocampus. Extracellular and intracellular activity was recorded from the CA1 and subicular regions in rats of the Wistar and Sprague-Dawley strains, anesthetized with urethane. In a subgroup of Wistar rats (23%), spontaneous afterdischarges (4.7+/-1.6 s) occurred regularly at 40.8+/-15.7 s. The afterdischarge was initiated by a fast increase of population synchrony (100-250 Hz oscillation; "tonic" phase), followed by large-amplitude rhythmic waves and associated action potentials at gamma and beta frequency (15-50 Hz; "clonic" phase). The afterdischarges were bilaterally synchronous and terminated relatively abruptly without post-ictal depression. Single-pulse stimulation of the commissural input could trigger afterdischarges, but only at times when they were about to occur. Commissural stimulation evoked inhibitory postsynaptic potentials in pyramidal cells. However, when the stimulus triggered an afterdischarge, the inhibitory postsynaptic potential was absent and the cells remained depolarized during most of the afterdischarge. Afterdischarges were not observed in the Sprague-Dawley rats. Long-term analysis of interneuronal activity in intact, drug-free rats also revealed periodic excitability changes in the hippocampal network at 0.025 Hz. These findings indicate the presence of an ultra-slow oscillation in the hippocampal formation. The ultra-slow clock induced afterdischarges in susceptible animals. We hypothesize that a transient failure of GABAergic inhibition in a subset of Wistar rats is responsible for the emergence of epileptiform patterns.
Subject(s)
Hippocampus/physiology , Pyramidal Cells/physiology , Rats, Wistar/physiology , Animals , Electric Stimulation , Evoked Potentials , Membrane Potentials , Motor Activity/physiology , Nerve Net/physiology , Oscillometry , Rats , Rats, Sprague-Dawley/physiology , Species Specificity , Theta RhythmABSTRACT
Adrenoceptors presently are classified into three main subclasses: alpha1-, alpha2-, and beta-receptors, each with three (perhaps more) subtypes. All three alpha1-adrenoceptor subtypes are present in rat brain. The purpose of this review is to assess the role of alpha1-adrenoceptors in the modulation of synaptic transmission and plasticity, as well as their ability to modulate higher cerebral functions, such as attentional and memory processes. However, since there are no truly subtype-specific agonists or antagonists available at present, it is virtually impossible to allocate a particular central effect to one or other of the subtypes. The activation of alpha1-adrenoceptors reduces the firing probability and glutamate release in the cornu ammonis of the hippocampus. Alpha1-Adrenoceptors may flexibly modulate weak and strong activation of the pyramidal neurones in the neocortex. Alpha1-Adrenoceptors play only a minor role in the modulation of long-term potentiation in the hippocampus, and may influence many brain functions also via non-neuronal mechanisms. since glial cells can express alpha1-adrenoceptors. At the behavioural level, the activation of alpha1-adrenoceptors promotes vigilance and influences working memory and behavioural activation, while having only a minor role in the modulation of long-term memory.
Subject(s)
Attention/physiology , Brain/physiology , Memory/physiology , Receptors, Adrenergic, alpha-1/physiology , Synaptic Transmission/physiology , Animals , Arousal/physiology , Cognition/physiology , Hippocampus/physiology , Humans , Learning/physiology , Long-Term Potentiation/physiologyABSTRACT
The present study compares the effects of two alpha 2-adrenoceptor agonists, clonidine (0.5, 2, and 5 micrograms/kg, p.o.), and guanfacine (7 and 29 micrograms/kg, p.o.), in young healthy volunteers on attentional performance. A placebo-controlled double-blind cross-over design (one drug dose/group) was employed. Neither of the drugs affected measures of motor performance or performance at easy levels in an attentional test. However, at the most difficult level in the attentional test, the highest dose of clonidine (5 micrograms/kg), but not guanfacine, decreased the number of correct responses and increased reaction latency. Clonidine 5 and guanfacine 29 micrograms/kg equally increased subjective feelings of sedation and reduced systolic and diastolic blood pressures. Thus, the effects of the drugs on attentional performance could be dissociated from their sedative effects. The results demonstrate that clonidine, but not guanfacine, disrupts performance in an attentional task requiring effortful processing, while leaving performance intact in tests requiring more automatic processing. The lower alpha 2A-vs. alpha 2C-adrenoceptor selectivity ratio of clonidine and the affinity for alpha 1-adrenoceptors of clonidine may be responsible for the different action of these drugs on attention.
Subject(s)
Adrenergic alpha-Agonists/pharmacology , Attention/drug effects , Clonidine/pharmacology , Guanfacine/pharmacology , Adult , Blood Pressure/drug effects , Cross-Over Studies , Double-Blind Method , Female , Humans , Male , Motor Activity/drug effects , Pain Measurement/drug effects , Psychomotor Performance/drug effects , Reaction Time/drug effectsABSTRACT
The present study investigated whether alpha-1 adrenergic and glutamatergic N-methyl-D-aspartate (NMDA) receptor-mediated mechanisms interact in memory processes, by examining the effects of individual and combined systemic administration of ST 587, a putative alpha-1 agonist, and D-cycloserine (DCS), a partial agonist at the glycine-B binding site of the NMDA receptor, on the performance of rats in non-delayed and delayed (4-6 h) foraging behaviour in the radial arm maze task, using the delayed non-matching to sample (DNMTS) version. The results indicated that DCS (5.0 mg/kg) decreased working memory errors, i.e. the number of re-entries into the previously visited arms during the sampling phase. In addition, both ST 587 (100 microg/kg) and DCS (10 mg/kg), when administered alone 30 min before a sampling phase, improved retention of this task as reflected by the increased number of correct choices before the first error during the retention phase. The combined administration of ST 587 and DCS, however, did not lead to better retention in the DNMTS task compared with the administration of each of the drugs alone. Combinations of sub-threshold doses of ST 587 (50 or 75 microg/kg) and DCS (5.0 or 7.5 mg/kg) also did not improve retention in this task. DCS (5.0 or 7.5 mg/kg) increased activity as indicated by the increased number of arm entries in a given time during the sampling phase. These findings suggest that the systemic administration of a positive modulator of the NMDA receptor facilitates hippocampal-dependent memory functions, but that these effects are not enhanced by combined administration with an alpha-1 agonist, even though the alpha-1 agonist is effective when given alone. The results support the idea that NMDA receptors modulate both mnemonic and non-mnemonic functions in the brain.
Subject(s)
Adrenergic alpha-Agonists/pharmacology , Appetitive Behavior/drug effects , Clonidine/analogs & derivatives , Cycloserine/pharmacology , Maze Learning/drug effects , Mental Recall/drug effects , Receptors, N-Methyl-D-Aspartate/agonists , Animals , Clonidine/pharmacology , Dose-Response Relationship, Drug , Drug Therapy, Combination , Male , Rats , Rats, Wistar , Retention, Psychology/drug effectsABSTRACT
We investigated the role of alpha2C-adrenoceptors in the modulation of spatial and non-spatial navigation behaviour. Alpha2C-adrenoceptor overexpressing mice developed an ineffective thigmotaxic search pattern characterized by swimming close to the pool walls during both spatial and non-spatial water maze training. A subtype-non-selective alpha2-adrenoceptor antagonist, atipamezole (1000 microg/kg, s.c.), fully reversed this impairment in their search strategy. Withdrawal of atipamezole at the end of spatial training resulted in an immediate disruption of the search pattern in alpha2C-adrenoceptor overexpressing mice. The swimming pattern of alpha2C-adrenoceptor overexpressing mice during a five day free swimming period was normal, when no cognitive component was required. Diazepam (0.3 and 1.0 mg/kg, i.p.), neither improved the accuracy in finding the platform nor decreased thigmotaxis. These results suggest that alpha2C-adrenoceptors may modulate the execution of complex navigation patterns.